{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:50:06Z","timestamp":1789995006351,"version":"4.0.1"},"reference-count":47,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2005,10,20]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Morphologic and immunohistochemical studies of familial breast cancers have identified specific characteristics associated with BRCA1 mutation-associated tumors when compared with BRCA2 and non-BRCA1\/2 tumors, but have not identified differences between BRCA2 and non-BRCA1\/2 tumors. Because BRCA1 and BRCA2 genes participate in the DNA repair pathway, we have performed an immunohistochemical study with markers related to this pathway to establish the profile of the three groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>We have studied two tissue microarrays that include 103 familial and 104 sporadic breast tumors, with a panel of DNA repair markers including ATM, CHEK2, RAD51, RAD50, XRCC3, and proliferating cell nuclear antigen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found more frequent expression of CHEK2 in BRCA1 and BRCA2 tumors than in non-BRCA1\/2 and sporadic tumors. We found absence of nuclear expression and presence of cytoplasmic expression of RAD51 in BRCA2 tumors that differentiate them from other familial tumors. We validated these results with a new series of patient cases. The final study with 253 familial patient cases (74 BRCA1, 71 BRCA2, 108 non-BRCA1\/2), and 288 sporadic patient cases, has allowed us to confirm our preliminary results. Because BRCA2 tumors present a specific immunohistochemical profile for RAD51 and CHEK2 markers that is different from non-BRCA1\/2 tumors, we have built a multivariate model with these markers that distinguish both tumors with an estimated probability of at least 76%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results suggest that BRCA2 tumors demonstrate more cytoplasmic and less nuclear RAD51 staining, and increased CHEK2 staining. This pattern may distinguish BRCA2 from familial non-BRCA1\/2 tumors.<\/jats:p><\/jats:sec>","DOI":"10.1200\/jco.2005.01.3698","type":"journal-article","created":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T21:57:40Z","timestamp":1129672660000},"page":"7503-7511","source":"Crossref","is-referenced-by-count":57,"title":["Immunohistochemical Expression of DNA Repair Proteins in Familial Breast Cancer Differentiate<i>BRCA2<\/i>-Associated Tumors"],"prefix":"10.1200","volume":"23","author":[{"given":"Emiliano","family":"Honrado","sequence":"first","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Osorio","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Palacios","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Milne","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orland","family":"D\u00edez","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Cazorla","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi","family":"Syrjakoski","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Huntsman","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Heikkil\u00e4","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Lerma","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kallioniemi","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rivas","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Foulkes","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Nevanlinna","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ben\u00edtez","sequence":"additional","affiliation":[{"name":"From the Human Genetics Department, Breast and Gynecological Cancer Laboratory, Immunohistochemical Unit, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, and the Genetics Department, Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, and the Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain; Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere, Finland; Genetic..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1038\/378789a0"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7545954"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1086\/301749"},{"key":"R4","unstructured":"Easton DF, Bishop DT, Ford D, et al: Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 52:678,1993-701,"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.4.994"},{"key":"R6","unstructured":"Hakansson S, Johannsson O, Johansson U, et al: Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet 60:1068,1997-1078,"},{"key":"R7","unstructured":"Serova OM, Mazoyer S, Puget N, et al: Mutations in BRCA1 and BRCA2 in breast cancer families: Are there more breast cancer-susceptibility genes? Am J Hum Genet 60:486,1997-495,"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1626"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"van Beers EH, van Welsem T, Wessels LF, et al: Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations. Cancer Res 65:822,2005-827,","DOI":"10.1158\/0008-5472.822.65.3"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1089"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1002\/humu.10260"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10109-4"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.09.023"},{"key":"R14","unstructured":"Palacios J, Honrado E, Osorio A, et al: Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: Differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. Clin Cancer Res 9:3606,2003-3614,"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-004-1536-0"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh115"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djg050"},{"key":"R18","unstructured":"Lakhani SR, Gusterson BA, Jacquemier J, et al: The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res 6:782,2000-789,"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh001"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00615-3"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-437X(98)80056-7"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Samuel T, Weber HO, Funk JO: Linking DNA damage to cell cycle checkpoints. Cell Cycle 1:162,2002-168,","DOI":"10.4161\/cc.1.3.118"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1038\/nature01368"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1038\/35004614"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1086\/341943"},{"key":"R26","unstructured":"Oldenburg RA, Kroeze-Jansema K, Kraan J, et al: The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1\/BRCA2 multiple-case families. Cancer Res 63:8153,2003-8157,"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Wang Y, Cortez D, Yazdi P, et al: BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14:927,2000-939,","DOI":"10.1101\/gad.14.8.927"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5428.747"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.23.6619"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)80276-2"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80503-6"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M001473200"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20169"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013517313008"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1186\/bcr953"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1593\/neo.04193"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11080"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1407"},{"key":"R39","doi-asserted-by":"crossref","unstructured":"Martinez-Ferrandis JI, Vega A, Chirivella I, et al: Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: Identification of three novel pathogenic mutations. Hum Mutat 22:417,2003-418,","DOI":"10.1002\/humu.9188"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20638"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi149"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1368"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206263"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0403"},{"key":"R45","unstructured":"Zhong Q, Boyer TG, Chen PL, et al: Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. Cancer Res 62:3966,2002-3970,"},{"key":"R46","unstructured":"Wang H, Zeng ZC, Bui TA, et al: Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2. Cancer Res 61:270,2001-277,"},{"key":"R47","unstructured":"Armes JE, Trute L, White D, et al: Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: A population-based study. Cancer Res 59:2011,1999-2017,"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2005.01.3698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T04:17:20Z","timestamp":1683260240000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2005.01.3698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,20]]},"references-count":47,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2005,10,20]]}},"alternative-id":["10.1200\/JCO.2005.01.3698"],"URL":"https:\/\/doi.org\/10.1200\/jco.2005.01.3698","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,20]]}}}